PAVmed Inc.

PAVM | NASDAQ

Price Alert Chart Builder DCF Calculator

$3.97

+$0.01 (+0.25%)

At close: Sep 21, 2026, 4:00 PM ET

$3.95

-$0.02 (-0.50%)

After-hours: Sep 21, 2026, 4:38 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

+0.25%

(1D)

Rating

Updated: Aug 11, 2026

Fundamentals Weak

Market Sentiment Neutral

Moat None

Full Analysis

Key Statistics

Market Data

Market Cap $25.34M

1D Range

3.79 4.01

52W Range

3.70 28.44

Valuation (TTM)

PE -0.24

PB 0.72

EV/EBITDA -0.01

Valuation (NTM)

Forward PE N/A

Forward PEG 0.01

Price Target $57

Cash Flow

FCF Yield -10359.3%

SBC Adj. FCF Yield -11083.6%

SBC Impact -7.0%

Margins

Gross Margin -254.5%

Operating Margin -21287.5%

FCF Margin -7936.0%

Growth (CAGR)

Revenue 3Y | 5Y 245.8% | 82.5%

Dil EPS 3Y | 5Y 151.3% | 57.9%

FCF 3Y | 5Y -144.0% | -90.2%

Returns

ROA -30.1%

ROE -33.5%

ROIC -72.8%

Financial Health

Net Debt

$11.32M

Current Ratio 1.19

Interest Coverage -1,483.56

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

PAVmed Inc. operates as a U.S.-based medical technology firm. Its principal commercialized products include CarpX, a percutaneous device designed to address carpal tunnel syndrome. Other key offerings...

Sector Healthcare

Industry Medical - Devices

Employees 41

IPO Date Jul 26, 2016

Website www.pavmed.com

Fiscal Year January - December

Full Company Profile

Latest News

No news articles available yet.

Earnings

Next Earnings

Nov 12, 2026

EPS Est

Pro

Rev Est

Pro

Earnings Details ➞

Analyst Summary

# of Analysts

Consensus

Buy

Price Target

$57

Upside

+1335.77%

Buy (1)

Hold (0)

Sell (0)

Analyst Details ➞